484 related articles for article (PubMed ID: 35883205)
1. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway.
Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S
Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205
[TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis.
Yuan M; Yao L; Chen P; Wang Z; Liu P; Xiong Z; Hu X; Li L; Jiang Y
Int Immunopharmacol; 2023 Dec; 125(Pt A):111134. PubMed ID: 37918086
[TBL] [Abstract][Full Text] [Related]
3. Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Hepatic Stellate Cell Activation and Liver Fibrosis by Upregulating MicroRNA-455-3p through Suppression of p21-Activated Kinase-2.
Zhou Q; Gu T; Zhang Y; Li H; Zhuansun X; Xu S; Kuang Y
Biomed Res Int; 2021; 2021():6685605. PubMed ID: 33708992
[TBL] [Abstract][Full Text] [Related]
4. A miR-340/SPP1 axis inhibits the activation and proliferation of hepatic stellate cells by inhibiting the TGF-β1/Smads pathway.
Zhang R; Wang M; Lu H; Wang J; Han X; Liu Z; Li L; Li M; Tian X; Chen S; Zhang G; Xiong Y; Li J
Adv Clin Exp Med; 2023 Apr; 32(4):469-479. PubMed ID: 36413180
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles from miR-148a-5p-Enriched Bone Marrow Mesenchymal Stem Cells Relieve Hepatic Fibrosis by Targeting Smad4.
Xuan J; Xu H; Li H; Chen D; Qiu Y; Chen X; Shao M; Xia X
Mol Biotechnol; 2022 May; 64(5):535-545. PubMed ID: 35006577
[TBL] [Abstract][Full Text] [Related]
6. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
7. HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis.
Lu H; Zhang R; Zhang S; Li Y; Liu Y; Xiong Y; Yu X; Lan T; Li X; Wang M; Liu Z; Zhang G; Li J; Chen S
Int Immunopharmacol; 2023 Nov; 124(Pt B):111002. PubMed ID: 37804655
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of hepatocyte-specific microRNAs in valproic acid mediated hepatic trans-differentiation of human umbilical cord derived mesenchymal stem cells.
Raut A; Khanna A
Exp Cell Res; 2016 May; 343(2):237-247. PubMed ID: 27001466
[TBL] [Abstract][Full Text] [Related]
10. PGE
Brea R; Motiño O; Francés D; García-Monzón C; Vargas J; Fernández-Velasco M; Boscá L; Casado M; Martín-Sanz P; Agra N
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):325-337. PubMed ID: 29109031
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
12. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p.
Kim J; Lee C; Shin Y; Wang S; Han J; Kim M; Kim JM; Shin SC; Lee BJ; Kim TJ; Jung Y
Mol Ther; 2021 Apr; 29(4):1471-1486. PubMed ID: 33348053
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord-derived mesenchymal stromal cells alleviate liver cirrhosis through the Hippo/YAP/Id1 pathway and macrophage-dependent mechanism.
Yao L; Hu X; Yuan M; Liu P; Zhang Q; Wang Z; Chen P; Xiong Z; Wu L; Dai K; Jiang Y
Int Immunopharmacol; 2023 Oct; 123():110456. PubMed ID: 37494836
[TBL] [Abstract][Full Text] [Related]
14. miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression.
Qiu J; Wu S; Wang P; Zhou Y; Wang Z; Sun Y; Jiang C
Hepatol Int; 2023 Apr; 17(2):463-475. PubMed ID: 36001230
[TBL] [Abstract][Full Text] [Related]
15. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
[TBL] [Abstract][Full Text] [Related]
16. miR-140-5p attenuates hepatic fibrosis by directly targeting TGFβR1.
Pan W; Wang Y; Zhao C
Scand J Gastroenterol; 2023; 58(11):1335-1343. PubMed ID: 37313731
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis.
Du Z; Wu T; Liu L; Luo B; Wei C
J Cell Mol Med; 2021 Jan; 25(2):701-715. PubMed ID: 33342075
[TBL] [Abstract][Full Text] [Related]
18. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells.
Ju B; Nie Y; Yang X; Wang X; Li F; Wang M; Wang C; Zhang H
J Cell Mol Med; 2019 Jun; 23(6):3824-3832. PubMed ID: 30945448
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
[TBL] [Abstract][Full Text] [Related]
20. Exosomes from adipose-derived mesenchymal stem cells improve liver fibrosis by regulating the miR-20a-5p/TGFBR2 axis to affect the p38 MAPK/NF-κB pathway.
Gan L; Zheng L; Yao L; Lei L; Huang Y; Zeng Z; Fang N
Cytokine; 2023 Dec; 172():156386. PubMed ID: 37852157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
